Global Lisinopril Market Companies

Pharmaceutical
Feb 2024
Global
350 Pages
No of Tables: 220
No of Figures: 60

Buy Now

Request for Sample

Nucleus

Companies Covered

Highest Market Share

Dominant Companies

Other Companies

Global Lisinopril Market Share Analysis

The data presented is for visualization purposes only and may not reflect actual results.

Nucleus : Company Analysis Platform

Request for Demo >

Frequently Asked Questions

Who are major players in lisinopril market?

Companies such as Lupin Pharmaceuticals, Inc. (India), AstraZeneca (U.K.), Merck & Co., Inc. (U.S.), Sun Pharmaceutical Industries Limited (India), Teva Pharmaceutical Industries Limited (Israel), Cipla Inc. (India) are major players in lisinopril market.

What are the recent product launches by major companies in the lisinopril market?

In April 2023, Aurobindo Pharma Ltd., a prominent player in the global generics market, announced the expansion of its cardiovascular product line with an upgraded formulation of Lisinopril targeting improved patient compliance and shelf life. This strategic move demonstrates the company’s commitment to addressing the growing burden of cardiovascular diseases, particularly in emerging economies. The initiative also reinforces Aurobindo’s competitive positioning in the global Lisinopril market by aligning product innovation with evolving healthcare needs

Which countries data is covered in the lisinopril market?

The countries covered in the lisinopril market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.